Solazyme - Biofuel IPO - 500 Beiträge pro Seite

[R-BgO]

im Mai an die Börse gegangen...:


May 27, 2011
SOLAZYME ANNOUNCES PRICING OF INITIAL PUBLIC OFFERING

SOUTH SAN FRANCISCO, Calif. -- Solazyme, Inc., a renewable oil and bioproducts company, today announced the pricing of its initial public offering of 10,975,000 shares of common stock at a price to the public of $18.00 per share. Of the shares of common stock in the offering, Solazyme is offering 10,375,000 shares, and selling stockholders are offering 600,000 shares. In addition, Solazyme has granted the underwriters a 30-day option to purchase up to an additional 1,646,250 shares of common stock, solely to cover over-allotments, if any. Solazyme will not receive any proceeds from the sale of shares by the selling stockholders.

Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. are acting as joint book-running managers for the offering. Jefferies & Company, Inc. is acting as lead manager, and Pacific Crest Securities LLC and Lazard Capital Markets LLC are acting as co-managers. The shares will begin trading on the NASDAQ Global Select Market on May 27, 2011 under the ticker symbol “SZYM.”

A registration statement relating to this offering was declared effective by the Securities and Exchange Commission on May 26, 2011. Any offer or sale will be made solely by means of a written prospectus forming part of the effective registration statement. Copies of the final prospectus relating to the offering may be obtained from: Morgan Stanley & Co. Incorporated,

Attn: Prospectus Department, 180 Varick Street, New York, NY 10014; or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282, telephone: [phone], facsimile: 212-902-9316 or by emailing [e-mail].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

[R-BgO]

June 30, 2011
SOLAZYME EXPANDS ALGENIST DISTRIBUTION CHANNELS TO INCLUDE SEPHORA CANADA AND THE SHOPPING CHANNEL

Canada's lead beauty retailers launch breakthrough, miracle ingredient, alguronic acid, throughout the country

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, has signed agreements with Sephora Canada and the leading Canadian multimedia retailer, The Shopping Channel®, to launch Algenist™, Solazyme's microalgae-based prestige anti-aging skincare line throughout the country. In an unprecedented beauty launch that couples world-class biotechnology with Canada's most prominent beauty retailers, the Algenist product line will begin selling in all 26 Canadian Sephora stores and on The Shopping Channel's highest rated beauty programming starting in July 2011.

Algenist is a product line of advanced anti-aging skincare products formulated with Solazyme's breakthrough ingredient, alguronic acid, an unexpected discovery which was found by the company's leading biotechnology scientists while researching microalgae for renewable energy solutions. When studied for potential anti-aging benefits, alguronic acid demonstrated significant results and outperformed some of the most well known anti-aging ingredients on the market including hyaluronic acid, retinol and vitamins C and E.

"Algenist comes from a lineage of biotechnology expertise that is not only pioneering the future of skincare, but reinvigorated the luxury skin and personal care space," said Frederic Stoeckel, Senior Vice President & General Manager, Solazyme Health Sciences. "Sephora and The Shopping Channel provide incredible support and access to some of the largest markets in the world and we look forward to a successful launch with their respective audiences in Canada."

"At Sephora, we are relentless in our search for exclusive and unique product offerings to redefine the Canadian beauty landscape. Algenist's pioneering work in producing microalgae ingredients from its biotechnology platform is a brand that is poised to do this," says Lori Castagna, VP/DMM Merchandising and Marketing, Sephora Canada. "Algenist is an extremely innovative addition to our skincare assortment and we look forward to introducing it to our discerning clients."

"The Shopping Channel is very excited to be launching the Algenist skin care line in Canada. Our buyers know that Canadian women are some of the most savy and discerning customers in the world, looking for great products, latest technologies and ultimately - results," said Lella Liuzzi, Vice-President, Merchandising, The Shopping Channel. "We are confident that both our existing customers and those who have yet to discover The Shopping Channel will embrace the Algenist brand. It's an excellent compliment to our already strong beauty brand assortment."

In March of 2011, Solazyme successfully launched the initial Algenist product portfolio in more than 850 retail Sephora stores worldwide and on QVC's lead beauty programming. Algenist ranked immediately after the launch as a top selling brand in both Sephora USA and on QVC.

The line of innovative alguronic acid based products will launch in Canada with three initial product offerings including the Algenist Concentrated Serum, the Algenist Anti-Aging Moisturizer, and the Algenist Complete Eye Renewal Balm. The Algenist Concentrated Serum minimizes the look of wrinkles and boosts skin radiance. The Algenist Anti-Aging Moisturizer nourishes and moisturizes skin, improves firmness, and minimizes the appearance of fine lines and wrinkles, while the Algenist Complete Eye Renewal Balm firms skin while minimizing the appearance of fine lines around the eye area.

About Solazyme, Inc.

Solazyme, Inc. (NASDAQ: SZYM) is a renewable oil and bioproducts company that transforms a range of low-cost plant-based sugars into high-value oils. Headquartered in South San Francisco, Solazyme's renewable products can replace or enhance oils derived from the world's three existing sources — petroleum, plants and animal fats. Initially, Solazyme is focused on commercializing its products into three target markets: (1) fuels and chemicals, (2) nutrition and (3) skin and personal care.

[Popeye82]

Antwort auf Beitrag Nr.: 41.852.515 von R-BgO am 27.07.11 15:04:50

Ist soweit ich gehört hab ein recht heiss gehandeltes +lang erwartetes IPO.

Fange mich jedenfalls selber, als einer der Sektoren of interest, immer mehr an für "advanced Biofuels(ab >/= 3.0 )" zu interessieren, wobei ich da noch ziemlich am Anfang steh´.

Gruß
P.

[R-BgO]

Antwort auf Beitrag Nr.: 41.853.588 von Popeye82 am 27.07.11 17:18:22

Welche Werte beobachtest Du?

Ich gucke im Bereich Biogas nach:
Envitec, Biogas Nord, MAX Automation, BKN Biostrom, BKN Bioenergy


und bei Biofuels nach:
Verbio, 2G-Bio Energy, Solazyme, und indirekt Novozyme und DuPont (Danisco)

[Popeye82]

Antwort auf Beitrag Nr.: 41.853.747 von R-BgO am 27.07.11 17:38:57

Sind eher ein paar kleine, exotisch &hochspekulative Buden die ich unter Beoacbhtung habe(OOIL:OB ist eines davon) -was eben jenem >/=3.0 geschuldet ist.

Gruß
P.

[Popeye82]

Antwort auf Beitrag Nr.: 41.853.872 von Popeye82 am 27.07.11 17:56:12

Hier sprechen die von "Second generation/advanced biofuels", wobei wir m.A.n. schon von einer 3. sprechen müssten -die ich fast ausschliesslich interessant finde/Chancen zuspreche -da sie IMO die 1ste ist, die die Problemfelder(v.a. was die Zweckentfremdung von Nahrungsmitteln angeht!) nahezu komplett ausschliesst/versucht zu umschiffen -was dann allerdings, natürlich, in technisch viel aufwendigeren Anforderungen resultiert. Mit entsprechenden Folgen sicher für den Entwicklungshorizont:
http://en.wikipedia.org/wiki/Biofuel#Second_generation_biofu…

in der dt. Version wird´s erwähnt:
http://de.wikipedia.org/wiki/Biokraftstoff

Gruß
P.

[R-BgO]

May 2, 2012
SOLAZYME AND DOW ENTER INTO CONTINGENT GLOBAL COMMERCIAL OFFTAKE AGREEMENT AND CONCURRENTLY SIGN PHASE 2 JOINT DEVELOPMENT AGREEMENT TO ACCELERATE COMMERCIALIZATION OF BIO-BASED DIELECTRIC INSULATING FLUIDS

New algal oil to provide higher flash point and increased functionality to dielectric insulating fluids for transformers and other electrical applications

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ: SZYM), a renewable oil and bioproducts company, and The Dow Chemical Company (NYSE: DOW), announced today that they have entered into a contingent offtake agreement in which Dow has agreed to purchase from Solazyme all of its requirements of non-vegetable microbe-based oils for use in dielectric fluid applications through 2015, contingent upon Solazyme's ability to supply such oils within agreed specifications and certain terms and conditions of the sale. These new, renewable and biodegradable bio-based dielectric insulating fluids offer increased fire safety thanks to higher flash points and provide additional functionality that may improve the operating efficiency and extend the useful life of transformers.

Concurrently, Solazyme and Dow have entered into a Phase 2 Joint Development Agreement (JDA2), an exclusive, multi-year extension of the current joint-development agreement including accelerated commercialization timelines based on Solazyme's rapid progress in the production of tailored algal oils. JDA2 enables additional application development work to be conducted by Dow, due to Solazyme's accelerated ability to scale up their uniquely tailored algal oil feedstocks. Consumption of Solazyme's algal oil feedstocks is expected to significantly exceed the minimum estimated volumes of 8.5 million gallons (29,000 metric tons) starting in the second half of 2013 and through 2015. The offtake agreement contemplates that final pricing for the oil will be linked to certain items including Solazyme's sugar-based feedstock costs.

"Solazyme's unique biotechnology-based oils platform has created a new market opportunity to develop and produce the next-generation of safe, renewable, dielectric insulating fluids that provide increased performance benefits," said Jonathan Wolfson, CEO, Solazyme. "We have continued to reach technological advancements ahead of schedule with Dow, enabling us to further progress our commercial relationship."

"Solazyme is a leading company in the industrial biotechnology space and its renewable oil technology platform provides a unique opportunity to significantly accelerate the development of next-generation, bio-based, non-vegetable dielectric insulating fluids," said Tim Laughlin, General Manager, Dow Electrical & Telecommunications. "In the fast-growing space of bio-based dielectric insulating fluids, Solazyme's tailored algal oils will serve as a technology platform for our continued efforts to bring innovative solutions to the power industry. Advanced field trials in transformers will be initiated to further prove the technology and value proposition of these new products in the near term. Based on the application work we have already completed to date, we are confident we are positioned to commercialize these oils in timelines consistent with Solazyme's planned ability to manufacture the quantities we need."

[R-BgO]

habe mir mal ein paar Ansichtsstücke zugelegt, um mich zu öfterem Hingucken zu "zwingen"

[Mojio]

Hat jemand ne Ahnung womit die Gesellschaft irgendwann mal Gewinne erzielen möchte?

Der Biodieselmarkt im Europa leidet unter Überkapazitäten und in Deutschland wird Biodiesel ab 2013 die teilweise Energiesteuerbefreiung aufgehoben. In wie weit sich andere Länder die Subventionen für Biodiesel leisten ist mir nicht ganz bekannt. In den USA scheint es aber ganz gute Förderungen von 1 Cent pro 1% im normalen Diesel zu geben.

Interessant scheint der Markt für chemische Produktie / Kosmetik und Nahrungsmittel zu sein. Hat sich hier jemand schon mit befasst?

[R-BgO]

Antwort auf Beitrag Nr.: 43.154.468 von R-BgO am 11.05.12 18:34:53

klappt ja super bisher...


weiter blutrote Zahlen, knapp 20 MUSD product sales

[Sorri]

Mann, ist das Ding runter geprügelt worden
Aktuell unter Cash gehandelt!!!!!

[Mistsack]

Antwort auf Beitrag Nr.: 48.404.408 von Sorri am 25.11.14 08:59:41

Ja, hab mittlerweile erste Positionen aufgebaut. Wenn die laufenden Produkte sich weiter gut im Markt etablieren, Encapso endlich auf Volumen kommt und sie auch die Stromprobleme in Moema endlich mal in den Griff bekommen ist der Laden viel mehr wert. Aktuell wird halt die Enttäuschung gespielt.

[Sorri]

40 % der Aktien leer verkauft
riecht nach Short SQUEZZE

[Aurum2010]

Noch wer dabei bei Solazyme? Der Titel hat sich etwas vom Tief bei USD 2.00 gelöst.

[Mistsack]

Ja, alles wird davon abhängen, dass man in Moema endlich den Stromanschluß hinbekommt und erste Umsätze mit Encapso zeigt. Dann kanns schnell wieder über 3$ gehen. Aktuell unterstützt auch der anziehende Ölpreis, obwohl Solazyme gar kein Biofuel stock mehr ist.

[Aurum2010]

Antwort auf Beitrag Nr.: 48.959.942 von Mistsack am 03.02.15 09:19:44

Zitat von Mistsack: Ja, alles wird davon abhängen, dass man in Moema endlich den Stromanschluß hinbekommt und erste Umsätze mit Encapso zeigt. Dann kanns schnell wieder über 3$ gehen. Aktuell unterstützt auch der anziehende Ölpreis, obwohl Solazyme gar kein Biofuel stock mehr ist.

Danke. Bist Du schon lange dabei? Was hast Du für Ziele? Solazyme hat ja enorm an Wert verloren, was ist hier ausser den Problemen mit dem Bau der Fabrik alles schief gelaufen?

Ich habe von Kurszielen über USD 30.00 gelesen, obwohl diese vermutlich von Goldmann Sachs angegeben worden sind da Sie den IPO von Solazyme begleitet haben...

[Mistsack]

Antwort auf Beitrag Nr.: 48.960.182 von Aurum2010 am 03.02.15 09:36:55

Hatte Solazyme schon lange auf der Watchlist, bin aber erst nach den letzten Quartalszahlen und dem Absturz zwischen 2,1-2,8$ rein. Mittelfristig will ich bei 3,5-4$ wieder raus. Ne kleinere Position werde ich langfrisitg behalten, da der Laden Potential bis 8$ hat.

Das Problem des Vereins ist der hohe Cash burn. Wenn man es nicht schafft Absatzmärkte für die eigenen Produkte zu finden, dann gehen irgendwann Mitte nächstes Jahr die Lichter aus. Aber man hat viele gute Ansätze: Kosmetik, Industrieöle und Nahrungsmittelzusatzstoffe.

Der Kurs kam halt auch runter, weil das Management in der Vergangenheit öfters die Erwartungen verfehlt hat. Hier wurde viel Porzellan zerschlagen. Aber die Plattform die sie haben ist super und vor allem der Bereich Nahrungsmittelzusätze birgt riesiges Potential. Aber wenn du noch nicht dabei bist, kannst du ja noch die nächsten Quartalszahlen abwarten.

[Aurum2010]

Antwort auf Beitrag Nr.: 48.960.803 von Mistsack am 03.02.15 10:27:02

Zitat von Mistsack: Hatte Solazyme schon lange auf der Watchlist, bin aber erst nach den letzten Quartalszahlen und dem Absturz zwischen 2,1-2,8$ rein. Mittelfristig will ich bei 3,5-4$ wieder raus. Ne kleinere Position werde ich langfrisitg behalten, da der Laden Potential bis 8$ hat.

Das Problem des Vereins ist der hohe Cash burn. Wenn man es nicht schafft Absatzmärkte für die eigenen Produkte zu finden, dann gehen irgendwann Mitte nächstes Jahr die Lichter aus. Aber man hat viele gute Ansätze: Kosmetik, Industrieöle und Nahrungsmittelzusatzstoffe.

Der Kurs kam halt auch runter, weil das Management in der Vergangenheit öfters die Erwartungen verfehlt hat. Hier wurde viel Porzellan zerschlagen. Aber die Plattform die sie haben ist super und vor allem der Bereich Nahrungsmittelzusätze birgt riesiges Potential. Aber wenn du noch nicht dabei bist, kannst du ja noch die nächsten Quartalszahlen abwarten.

Danke für den guten Überblick. Ich bin bereits dabei, erachtete die aktuellen Kurse als gute Einstiegskurse. Mal schauen wie es mit dem stärkeren Ölpreis heute weitergeht.

[Mistsack]

Antwort auf Beitrag Nr.: 48.961.328 von Aurum2010 am 03.02.15 11:05:10

Sollte es nochmal deutlich unter 2$ gehen, werde ich sicherlich nochmal nachkaufen. Aktuell bin ich ganz zufrieden mit der Position, da sie in Dollar notiert und allein die Wechselkursgewinne aktuell einen guten Puffer bieten.

[Aurum2010]

Feb 12, 2015

Solazyme to Announce Fourth Quarter and Full Year 2014 Financial Results on February 26, 2015

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and ingredients company, today announced it will host a conference call and webcast on Thursday, February 26, 2015 at 4:30 p.m. Eastern Time to discuss its fourth quarter and full year 2014 financial results.

The call and webcast will follow the release of fourth quarter and full year 2014 financial results after market close. A recorded version of the call will be available approximately two hours after the call at the Investor Relations portion of the company's website, www.solazyme.com.

Conference Call Details

What: Solazyme's fourth quarter and full year 2014 financial results conference call and webcast

Date: Thursday, February 26, 2015

Time: 4:30 p.m. Eastern Time

Live call: [phone]

International: [phone]

Audio Replay: [phone]

Passcode: 82746845

The webcast will be archived through March 5, 2015.

About Solazyme, Inc.

Solazyme, Inc. (Nasdaq:SZYM) is the leading microalgae innovator that delivers first-of-a-kind, high-performance oils and ingredients that are better for people and better for the planet. Starting with microalgae, the world's original oil producer, Solazyme creates new, sustainable, high-performance products. These include renewable oils and ingredients that serve as the foundation for healthier foods; better home, personal care and industrial products; and more sustainable fuels. Headquartered in South San Francisco, Solazyme's mission is to solve some of the world's biggest problems with one of its smallest and most ancient life forms: microalgae.

[Aurum2010]

Antwort auf Beitrag Nr.: 49.058.291 von Aurum2010 am 13.02.15 08:29:38

Solazyme Receives FDA GRAS No Questions Letter for High Oleic Algae Oil
SAN FRANCISCO--(BUSINESS WIRE)-- Solazyme, Inc. (NASDAQ:SZYM), a renewable oil and ingredients company, is pleased to announce that the US Food and Drug Administration (FDA) has issued a favorable response to Solazyme's notification which concludes that high-oleic algae oil is Generally Recognized as Safe (GRAS) as an ingredient in food products under the intended conditions of use.

This No Questions letter will further pave the way for mainstream adoption of superior quality oleic algae oil with unprecedented functional, performance and nutritional benefits, enabling the creation of new products that meet consumer demand for healthy, sustainable ingredients.

Solazyme's portfolio of high oleic algae oils are unique in that they can offer an unprecedented amount of healthy monounsaturated fat (omega-9s), and 0g trans fat with exceptional stability and low levels of saturated fat. They have a very light color and neutral flavor allowing the flavor of foods to come through in recipes. Solazyme's High Stability High Oleic algae oil received the prestigious 2014 Innovation Award from the Institute of Food Technologists.

"We're committed to delivering innovative ingredients that are better for both people and the planet. Our algae oils offer more favorable fat profiles than olive oil, and higher smoke points than canola, helping customers respond to the growing demand for great tasting and nutritious food," said Mark Brooks, SVP, Solazyme Food Ingredients.

Solazyme has also received FDA No Questions letters for the whole food ingredient products currently offered within the AlgaVia™ portfolio, including Whole Algal Protein and Whole Algal Flour.

Whole Algal Protein is a vegan-friendly, gluten-free product that contains a rich collection of protein with fiber, lipids and micronutrients such as lutein and zeaxanthin. With a protein that is protected by a natural cell wall, this ingredient enables fortification in challenging applications such as low pH beverages, dressings and crackers.

Whole Algal Flour is a trans-fat- and cholesterol-free lipid powder that enables the creation of healthier products with satisfying taste and texture. This new fat source enables the reduction or replacement of dairy fats, oil and egg yolks.

[Mistsack]

es geht voran. Bin mal gespannt was sie morgen nach Börsenschluß erzählen. Vor allem Moema wird entscheidend für die weitere Kursentwicklung.

[Aurum2010]

Solazyme Reports Fourth Quarter and Full Year 2014 Results
Continued progress at Solazyme Bunge Renewable Oils plant

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--

Solazyme, Inc. (SZYM), a renewable oil and bioproducts company, announced today results for the fourth quarter and full year ended December 31, 2014.

“Although 2014 was a challenging year, we made great strides against our commercialization and production goals, including launching Encapso™ and our AlgaVia™ microalgae food ingredients, and starting up operations at our Clinton/Galva and SB Oils Moema facilities,” said Jonathan Wolfson, CEO of Solazyme. “We ended 2014 by demonstrating fully integrated operations at Moema and are confident that we will turn the corner to consistent and reliable operations as well. We have great technology, products and partners and though there is hard work in front of us we are excited about our opportunities and the year ahead.”

Financial Results

Total revenue for the fourth quarter of 2014 was $14.5 million compared with $11.3 million in the fourth quarter of 2013, an increase of 29%. Fourth quarter GAAP net loss was $44.9 million compared to a net loss of $33.3 million in the prior year period. On a non-GAAP basis, the net loss was $35.5 million for the fourth quarter of 2014 compared to a net loss of $27.4 million in the prior year quarter. A reconciliation of GAAP to non-GAAP results is included below.

Total revenue for the year ended December 31, 2014 was $60.4 million compared with $39.8 million in the prior year, an increase of 52%, with the product revenue component of that up 87% versus the prior year. Full year 2014 GAAP net loss was $162.1 million, compared with $116.4 million loss in the prior year. On a non-GAAP basis, the net loss was $133.4 million for 2014, compared with $88.6 million in 2013.

“Solazyme’s 2014 revenue growth reflects the continued expansion of our Algenist® product line, shipments from Clinton/Galva and Peoria of Encapso™ and AlgaVia™ branded products, as well as delivery against all of our joint development milestones for our partners,” said Tyler Painter, COO and CFO of Solazyme. “We are focused on maximizing the returns on our capacity investments and driving efficiencies across our operations. We are well positioned financially to accelerate the commercialization of our products in 2015.”

Business Review

Moema: In December, we demonstrated the ability to operate on a fully integrated basis at Moema, achieving a major technical milestone for the company by demonstrating integrated operations from input sugar to crude oil. Our goal at Moema in 2015 is to reach consistent fully integrated operations and ramp production volumes.
Clinton/Galva: We began commercial production in Clinton and Galva and successfully produced five unique products during the course of the year.
Encapso™: Solazyme introduced Encapso™, the world’s first commercially-available, biodegradable encapsulated oil for use as a lubricant in drilling fluids. Commercial rig results have confirmed that Encapso™ delivered operational improvements such as reductions in torque, increases in drilling speed, and reductions in non-productive time during use in 37 commercial wells.
AlgaVia™: In 2014, we launched our microalgae food ingredients business under the AlgaVia™ brand name. The lipid and protein powders, as well as our high oleic algae oil, are Generally Recognized as Safe (GRAS) in the US and have received “No Questions” letters from the FDA.
Partner Developments: In 2014, we made our first deliveries under a 10k MT supply agreement and extended our Joint Development Agreement (JDA) with Unilever; expanded our JDA and established key terms for a five year supply agreement targeting up to 10k MT/year with AkzoNobel; partnered with Versalis to commercialize Encapso™; and met all JDA targets with Mitsui.

[Aurum2010]

@Mistsack

Warste zufrieden mit den Zahlen?

Sag mal was läuft da mit Roquette, Solazyme hat mit Roquette nen "judge on 4-6-15 at 4:30pm"

[Aurum2010]

Erste Wiederstände durchbrochen

3.07 +0.32 (11.64%)

[Mistsack]

Antwort auf Beitrag Nr.: 49.257.497 von Aurum2010 am 06.03.15 10:35:48

Zitat von Aurum2010: @Mistsack

Warste zufrieden mit den Zahlen?

Sag mal was läuft da mit Roquette, Solazyme hat mit Roquette nen "judge on 4-6-15 at 4:30pm"

Na ja....Zahlen waren so la la. Alle gucken eh auf Moema und da scheint es ja auch Fortschritte zu geben. Was ganz positiv stimmt, ist das Algenist mittlerweile gute Umsätze und Marge abwirft. Gefühlt könnte die Marke alleine 100Mio. MK abdecken. Zu Encapso und Co gabs leider nicht viel belastbares. Was auffällt ist, dass von Q3 auf Q4 der Umsatz gefallen ist. Könnte ein schlechtes Zeichen sein.

Mit Roquette gab es mal eine Zusammenarbeit bei der Entwicklung von Zusatzstoffen für Nahrungsmittel. (macht man heute mit Unilever und finde ich auch besser) Roquette ist dann Hals über Kopf aus dem JV ausgestiegen und hat eine Menge Patente aus gemeinsamen Entwicklungen für sich beansprucht. Hier hat Solazyme vor dem Arbitration court wohl Recht bekommen, was ihre Position stärkt. Siehe Conference call

Der Kursanstieg gestern wurde wohl durch einen Insiderkauf (140.000Aktien durch Jerry Fiedler) getriggert. Das scheint zu einem short squeeze geführt zu haben.

http://investors.solazyme.com/sec.cfm?DocType=&Year=&SortOrd…

[Aurum2010]

Antwort auf Beitrag Nr.: 49.308.116 von Mistsack am 12.03.15 09:54:27

Zitat von Mistsack:

Zitat von Aurum2010: @Mistsack

Warste zufrieden mit den Zahlen?

Sag mal was läuft da mit Roquette, Solazyme hat mit Roquette nen "judge on 4-6-15 at 4:30pm"

Na ja....Zahlen waren so la la. Alle gucken eh auf Moema und da scheint es ja auch Fortschritte zu geben. Was ganz positiv stimmt, ist das Algenist mittlerweile gute Umsätze und Marge abwirft. Gefühlt könnte die Marke alleine 100Mio. MK abdecken. Zu Encapso und Co gabs leider nicht viel belastbares. Was auffällt ist, dass von Q3 auf Q4 der Umsatz gefallen ist. Könnte ein schlechtes Zeichen sein.

Mit Roquette gab es mal eine Zusammenarbeit bei der Entwicklung von Zusatzstoffen für Nahrungsmittel. (macht man heute mit Unilever und finde ich auch besser) Roquette ist dann Hals über Kopf aus dem JV ausgestiegen und hat eine Menge Patente aus gemeinsamen Entwicklungen für sich beansprucht. Hier hat Solazyme vor dem Arbitration court wohl Recht bekommen, was ihre Position stärkt. Siehe Conference call

Der Kursanstieg gestern wurde wohl durch einen Insiderkauf (140.000Aktien durch Jerry Fiedler) getriggert. Das scheint zu einem short squeeze geführt zu haben.

http://investors.solazyme.com/sec.cfm?DocType=&Year=&SortOrd…

Danke für deine Antwort. Ja ich denke auch der Insiderkauf + das durchbrechen der USD 2.80 waren für den Short squeeze geführt haben.

Habe gestern auch da ich einen Überkauf sehe realisiert, knapp 50& waren zu verlockend

Wenn ich die SEC's von gestern Abend richtig deute, hat es aber bereits wieder einige Verkäufe gegeben.

[Mistsack]

Antwort auf Beitrag Nr.: 49.308.347 von Aurum2010 am 12.03.15 10:12:15

Ja, da laufen automatisierte Verkäufe entsprechend langfristiger Pläne. Das ist bei Wolfson und Co schon relativ lange so. Es gibt nur ein 20TAges Fenster nach den Zahlen, wo das möglich ist. Aber es war das erste mal seit langem, dass ein Insider hier kauft.

Bist du jetzt raus?

[Aurum2010]

Antwort auf Beitrag Nr.: 49.310.399 von Mistsack am 12.03.15 13:26:11

Zitat von Mistsack: Ja, da laufen automatisierte Verkäufe entsprechend langfristiger Pläne. Das ist bei Wolfson und Co schon relativ lange so. Es gibt nur ein 20TAges Fenster nach den Zahlen, wo das möglich ist. Aber es war das erste mal seit langem, dass ein Insider hier kauft.

Bist du jetzt raus?

Ja ich bin jedoch auf der lauer aber denke der Anstieg muss nun etwas verdaut werden.

[Aurum2010]

@Mistsack, bin beim gestrigen Taucher um USD 2.70 wieder rein.

[R-BgO]

war sehr lange nicht mehr hier;

glaubt wirklich jemand, die könnten irgendwann die Kurve kriegen?

Wenn ich schon sehe, dass sie alleine für Verwaltung den 1,5 fachen Umsatz ausgeben...

[Aurum2010]

Solazyme wieder um den USD 2.80 Wiederstand... Kurs Katalysator die Verhandlung vs. Roquette, hier könnten ein paar Mio. in die Kasse von Solazyme fliessen.

[Mistsack]

Antwort auf Beitrag Nr.: 49.347.254 von Aurum2010 am 17.03.15 08:05:12

Zitat von Aurum2010: @Mistsack, bin beim gestrigen Taucher um USD 2.70 wieder rein.

gratuliere....hast du ja nochmal einen guten Einstieg erwischt.

[Mistsack]

Antwort auf Beitrag Nr.: 49.349.039 von R-BgO am 17.03.15 11:00:04

Zitat von R-BgO: war sehr lange nicht mehr hier;

glaubt wirklich jemand, die könnten irgendwann die Kurve kriegen?

Wenn ich schon sehe, dass sie alleine für Verwaltung den 1,5 fachen Umsatz ausgeben...

Dir ist aber schon klar, dass da viel R&D drin ist, oder? Ich denke, der Ansatz hat Potential und kann ein Game changer werden. Es gibt einfach viele Bereich in welchen Sie mit Ihren Algen neue Produkte generieren können. Gehe eh davon aus, dass der Laden über kurz oder lang übernommen wird, wenn sich abzeichnet, dass man die Kurve kriegt.

[R-BgO]

Antwort auf Beitrag Nr.: 49.378.475 von Mistsack am 19.03.15 23:54:47

leider falsch!

aus dem 10k:

Revenue 60,391 MUSD
SGA 90,266
R&D 81,680

wenn Dir da nicht klar war, dann war Deine Analyse wohl eher qualitativer Natur...

[Mistsack]

Antwort auf Beitrag Nr.: 49.380.545 von R-BgO am 20.03.15 10:19:05

Die Überleitung von GAAP zu "Non-GAAP" weist 25Mio $ stock based compensation aus, 18Mio davon bei S&A. Kann man drüber streiten, aber zumindest kostet es kein cash. Aber du hast recht, S&A > revenue...mein Fehler.

Operating expenses sollen 2015 im Rahmen der laufenden Restrukturierung übrigens um weitere 18Mio $ gedrückt werden.

[Aurum2010]

Solazyme wieder über USD 3.00.

Gutes Video falls noch nicht bekannt:
https://www.youtube.com/watch?v=osv9SJ_Uo18

Das Potential ist gewaltig, bin sehr gespannt wie es hier weitergeht.

[Aurum2010]

Zwar vom 30.03.15 aber dennoch lesenswert:

Solazyme Positions Itself In The Challenged Market For Clean-Label Foods
http://seekingalpha.com/article/3037456-solazyme-positions-i…

[Aurum2010]

Flotek Industries and Solazyme Announce Strategic Agreements to Develop and Market Advanced Drilling Fluid Technologies and Expand Marketing of Encapso(TM) in the Middle East

HOUSTON & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Flotek Industries, Inc. (NYSE:FTK) ("Flotek") and Solazyme, Inc. (NASDAQ:SZYM) ("Solazyme") today announced the companies and certain subsidiaries have entered into agreements to globally commercialize Flocapso™, an innovative, advanced drilling fluid additive. In addition, Flotek will market Solazyme's Encapso™ lubricant - the first commercially available, biodegradable encapsulated lubricant for drilling fluids - in certain Middle Eastern markets.

Under the Joint Product Development and Marketing Agreement (the "Joint Agreement"), Flotek and Solazyme will commercialize and market Flocapso, a proprietary formulation combining Flotek's patented Complex nano-Fluid® chemistries with Solazyme's proprietary Encapso technology to create an environmentally-conscious, highly effective drilling fluid additive focused on better lubricity and greater stabilization for drilling programs worldwide. Laboratory and commercial testing indicate that the Flocapso additive will allow the use of water-based fluids in wells that previously required more expensive and invasive oil-based products, providing an environmentally superior, more efficient solution to drilling challenges around the globe.

"Our partnership with Solazyme is another important step in Flotek's quest to identify and partner with innovative and efficacious technologies that advance oilfield chemistry for the benefit of our clients," said John Chisholm, Chairman, President and Chief Executive Officer of Flotek. "Solazyme's development of Encapso and its rapid recognition as a break-through lubricant in drilling applications is testament to Solazyme's world-class research team. We are delighted to have an opportunity to work with the Solazyme team as we continue our focus on developing the best chemistry solutions for the oilfield."

"We are excited to add Flotek as a strategic partner as we continue to focus on broadening the market and customer base for Encapso," said Solazyme Chief Executive Officer Jonathan Wolfson. "As a leading, global technology company with a focus on oilfield chemistry, Flotek brings new opportunities to expand sales of Encapso in the Middle East, as well as to commercialize and jointly market Flocapso, a unique and high performance product that provides a large global sales opportunity to satisfy an unmet need through the combination of superior technologies. The new Flocapso drilling solution is designed to provide significant advantages in lubricity and stabilization and a much cleaner environmental footprint."

Under the Joint Agreement, Flotek and Solazyme will continue the development of the Flocapso chemistries and work cooperatively to market Flocapso worldwide. The companies are currently in an active validation project with a large national oil company in the Middle East and are pursuing commercial applications in both domestic and international markets.

Winner of the Presidential Green Chemistry Challenge Award, Solazyme launched Encapso in early 2014. With its unique, targeted lubricant delivery system, Encapso has shown to increase the rate of penetration, decrease drag and reduce both rotational torque and friction in a variety of vertical and horizontal drilling applications. This can lead to lower drilling costs, reduced non-productive time, and accelerated operations. Developed from Solazyme's proprietary technology platform, Encapso is non-toxic and biodegradable.

Flotek's Complex nano-Fluid, or CnF®, chemistries are a series of proprietary, patented chemistries designed to enhance performance in oil and natural gas wells, including increased productivity through improved production rates and higher ultimate recoverability. The proprietary combination of citrus-based solvents and surfactants which are combined to create a nano-molecular chemistry provide unique benefits in the drilling process.

"Last year we acquired certain intellectual property related to the use of CnF in drilling fluid applications from Tony Rea, a drilling fluid technology pioneer, which led to discussions and chemical trials with Solazyme," said Chisholm. "As a result of Tony's work showing the efficacy of using CnF to improve drilling results and the combination of Solazyme's Encapso, we developed Flocapso, a drilling fluid additive that we believe will provide significant improvements to drilling efficiency and effectiveness around the globe."

In addition, the companies have entered into a Strategic Alliance Agreement (the "Agreement") whereby Solazyme has granted Flotek exclusive distribution rights to sell and market Encapso as a drilling fluid lubricant in certain territories in the Middle East. In exchange, Flotek has agreed to certain minimum purchases of Encapso from Solazyme in the initial year of the Agreement.

"We are excited about the opportunity to work closely with Solazyme to promote the use of the Encapso lubricant in the Middle East and beyond," added Chisholm. "Our work with the Solazyme team and Encapso gives us great confidence that this game-changing technology has broad applications in many markets, especially those in which we have established relationships. Combined with our jointly developed Flocapso product, we believe this Agreement creates a meaningful advantage for Flotek as we continue to develop Middle Eastern markets."

"Flotek's expertise, infrastructure and established and emerging relationships in the Middle East make them an outstanding partner for Solazyme and Encapso," added Wolfson. "Combined with our relationships and product support team, we believe the Flotek partnership provides an excellent opportunity to accelerate market adoption of Encapso, both through certain of Flotek's distribution and sales channels in the Middle East, and through sales of the combined Flocapso drilling fluid additive worldwide."

About Flotek Industries, Inc.

Flotek is a global developer and distributor of a portfolio of innovative oilfield technologies, including specialty chemicals and down-hole drilling and production equipment. It serves major and independent companies in the domestic and international oilfield service industry. Flotek Industries, Inc. is a publicly traded company headquartered in Houston, Texas, and its common shares are traded on the New York Stock Exchange under the ticker symbol "FTK."

For additional information, please visit Flotek's website at www.flotekind.com.

[Aurum2010]

Was meint Ihr, ist nach dieser News mit einer KE / Dilution zu rechnen oder ist Solazyme noch genügend komfortabel Liquide?

[R-BgO]

Antwort auf Beitrag Nr.: 49.559.000 von Aurum2010 am 14.04.15 13:05:03

Thread: Flotek Industries - Fracking Zulieferer

[Aurum2010]

Bin gestern wieder raus, denke ist wieder Überkauft (RSI gegen 80)
Habe jedoch etwas tiefer bereits wieder eine Order gestellt

[Mistsack]

Es sieht ein bisschen so aus als wöllte der Chart die Lücke, die bei der Gewinnwarnung letzten Herbst bei 6$ gerissen wurde, schließen. Aber klar...mächtig überhitzt.

Der Deal mit Flotek ist interessant da Flotek ein relativ innovativer Dienstlöeister im Shale Gas Bereich ist. Außerdem zeigt er, dass die Produkte von Solazyme scheinbar einen Markt haben.

Nächste Trigger für weitere Kursanstiege könnten der Netzanschluß in Moema oder ein Abschluß mit einem Nahrungsmittelkonzern sein.

[Aurum2010]

Antwort auf Beitrag Nr.: 49.586.012 von Mistsack am 17.04.15 09:59:12

Zitat von Mistsack: Es sieht ein bisschen so aus als wöllte der Chart die Lücke, die bei der Gewinnwarnung letzten Herbst bei 6$ gerissen wurde, schließen. Aber klar...mächtig überhitzt.

Der Deal mit Flotek ist interessant da Flotek ein relativ innovativer Dienstlöeister im Shale Gas Bereich ist. Außerdem zeigt er, dass die Produkte von Solazyme scheinbar einen Markt haben.

Nächste Trigger für weitere Kursanstiege könnten der Netzanschluß in Moema oder ein Abschluß mit einem Nahrungsmittelkonzern sein.

Danke für deine Meinung welche ich sehr schätze!

Gehe ich richtig in der Annahme, dass sollte Solazyme keinen Deal in nächster Zeit tüten, wird eine KE notwendig welche dann ein guter Wiedereinstieg wäre!?

[Mistsack]

Antwort auf Beitrag Nr.: 49.588.646 von Aurum2010 am 17.04.15 13:54:02

Na ich gehe mal davon aus, dass Solazyme so oder so eine KE brauchen wird. Das Geld reicht nur noch bis Anfang / Mitte 2016 und die neuen Deals werden nicht soviel Cash generieren, dass man das um Jahre verzögern kann.

Ich denke aber eher, dass man den Kurs vorher Richtung 6-7€ bewegen wird, bevor man etwas in die Richtung unternimmt. Aktuell sind hier vermutlich noch zu viele Aktionäre im Minus als das die KE ohne Probleme durchgeht.

[Aurum2010]

Antwort auf Beitrag Nr.: 49.588.883 von Mistsack am 17.04.15 14:16:12

Kommen langsam in einen Kursbereich wo ein Einstieg wieder spannend wäre

[Mistsack]

Antwort auf Beitrag Nr.: 49.643.468 von Aurum2010 am 25.04.15 18:37:31

wenn ich mich recht erinnere kommen am 6. Mai Zahlen. Da könnte es wieder zu größeren Kursbewegungen kommen. Die Frage bleibt: welche Richtung?

[Aurum2010]

Antwort auf Beitrag Nr.: 49.644.749 von Mistsack am 26.04.15 10:07:08

Zitat von Mistsack: wenn ich mich recht erinnere kommen am 6. Mai Zahlen. Da könnte es wieder zu größeren Kursbewegungen kommen. Die Frage bleibt: welche Richtung?

Ja am 6. Mai kommen die Zahlen nach Börsenschluss. Mein Auftrag wurde gestern knapp nicht bedient... Mal schauen ev. klappt es noch mit dem netten Wiedereinstieg vor den Zahlen.

[Mistsack]

Antwort auf Beitrag Nr.: 49.668.189 von Aurum2010 am 29.04.15 09:33:27

Zitat von Aurum2010: Ja am 6. Mai kommen die Zahlen nach Börsenschluss. Mein Auftrag wurde gestern knapp nicht bedient... Mal schauen ev. klappt es noch mit dem netten Wiedereinstieg vor den Zahlen.

Das ist dumm gelaufen. Heute zerrt der steigende Ölpreis alle Öltitel hoch und Solazyme profitiert auch. Der Markt sieht sie halt immer noch als oil play.

[Aurum2010]

Antwort auf Beitrag Nr.: 49.674.909 von Mistsack am 29.04.15 18:54:31

Zitat von Mistsack:

Zitat von Aurum2010: Ja am 6. Mai kommen die Zahlen nach Börsenschluss. Mein Auftrag wurde gestern knapp nicht bedient... Mal schauen ev. klappt es noch mit dem netten Wiedereinstieg vor den Zahlen.

Das ist dumm gelaufen. Heute zerrt der steigende Ölpreis alle Öltitel hoch und Solazyme profitiert auch. Der Markt sieht sie halt immer noch als oil play.

Dayrange 3.70 - 4.34... Krasser Sell-Off am ende mit kleiner Korrektur.
Kauf um einen Cent verpasst

[Aurum2010]

Heute hast geklappt mit der Order, hoffe gute Entscheidung mit einer Pos. durch die Zahlen zu gehen.

[MIRU]

Antwort auf Beitrag Nr.: 49.690.287 von Aurum2010 am 01.05.15 16:06:51

Die gehen nochmal unter 3 USD. Dann kann man in Ruhe zurückkaufen.

[Aurum2010]

Antwort auf Beitrag Nr.: 49.690.662 von MIRU am 01.05.15 17:00:15

Zitat von MIRU: Die gehen nochmal unter 3 USD. Dann kann man in Ruhe zurückkaufen.

Vor den Zahlen kaum. Die Zahlen werden die weitere Richtig zeigen.

[Aurum2010]

Solazyme's Encapso: An Essential Ingredient In The American Shale Revolution
http://seekingalpha.com/article/3131016-solazymes-encapso-an…

[Aurum2010]

Gestern satter Start bis zu USD 4.00 Marke dann fast den gesammten Gewinn wieder abgegeben...

Folgender Artikel ist noch Spannend:

Solazyme Investors Await Moema Update, But This Is More Important
http://www.fool.com/investing/general/2015/04/28/solazyme-in…

[Aurum2010]

2 Easy Ways Solazyme Can Unlock Value for Its Most Profitable Brand
http://www.fool.com/investing/general/2015/05/05/2-easy-ways…

[Aurum2010]

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--

Solazyme, Inc. (SZYM), a renewable oil and bioproducts company, announced today results for the first quarter ended March 31, 2015.

“We are executing against our operating plan for 2015 and are pleased with the progress we are seeing across the company and in our manufacturing and commercialization efforts specifically,” said Jonathan Wolfson, CEO of Solazyme. “Advances are being made at the Moema JV production facility in Brazil including substantial improvements in downstream processing efficiency and oil production as well as in overall up-time and integrated operations. On the commercial side, we are moving forward as well. Recent progress includes the announced Flotek strategic partnership for Encapso™ and Flocapso™, new AlgaVia™ food ingredient customers and the expansion of our relationship with Bunge to cover a next generation food ingredient.”

Financial Results

Total revenue for the first quarter ended March 31, 2015 was $12.6 million compared with $12.4 million in the first quarter of 2014, while product revenue of $8.8 million was up 20% versus the comparable quarter. GAAP net loss was $34.7 million for the first quarter of 2015, unchanged from the first quarter of the prior year. On a non-GAAP basis, the net loss was $29.5 million for the first quarter of 2015, compared with net loss of $30.5 million in the prior year quarter. A reconciliation of GAAP to non-GAAP results is included below.

“During the first quarter, we continued to build the market for our AlgaVia™ food ingredients business, which had its best quarter yet, and our Algenist® personal care brand turned in 26% year-on-year growth,” said Tyler Painter, COO and CFO of Solazyme. “We are focused on sales as well as overall financial performance and continue to believe that we are well positioned to profitably commercialize our products globally.”

Business Review

Moema: During the first quarter of 2015, we experienced improved downstream recovery rates from production and were able to run greater volumes through the facility. Although we continue to experience some power and steam intermittency, fixes implemented to date have led to improved reliability, and we have experienced multi-week periods where the facility has run on a continuous, fully integrated basis. Key steam and power redundancy projects remain on track to be completed by the end of the second quarter.

Encapso™: We reached a strategic alliance agreement with Flotek under which Flotek will market Solazyme’s Encapso, the first commercially available, biodegradable encapsulated lubricant for drilling fluids, in certain Middle Eastern markets. The companies also reached a joint product development and marketing agreement to globally commercialize Flocapso™, an innovative, advanced drilling fluid. During the quarter, we also secured our first customer in South America, further expanding Encapso’s geographic reach.

Algenist®: We had another quarter of double digit year-on-year revenue growth as we continue to grow and expand our Algenist brand, which is now distributed in 22 countries with 36 SKUs. We currently have two new launches in process including a Genius Bi-Phase Peel at Sephora and QVC and Sublime Defense Anti-Aging Moisturizer with SPF 30, launching at QVC, Sephora, Ulta and select Nordstrom locations.

AlgaVia™: First quarter revenues were the highest to date for our AlgaVia food ingredient product line. We continue to add new projects with food and beverage manufacturers, as well as three new customers for lipid powders and protein ingredients.

Partner Developments: We expanded our relationship with Bunge and entered into a new joint development agreement for a next generation food ingredient.

[Mistsack]

kurzer Kommentar zu den Zahlen:

Umsatz fand ich enttäuschend, das man die Kosten etwas besser im Griff hat ist gut. In Moema scheint sich endlich was zum guten zu wenden. Allerdings ist mir nicht klar, wer im Moment die Produkte kaufen soll, die da produziert werden sollen. Habe nicht das Gefühl das man aktuell "production constrained" ist. Daher vermutlich auch das abbröckeln im Kurs.

Moema Netzanschluß könnte noch einmal ein Trigger für nen kurzen Anstieg sein. Ansonsten müssen sie langsam mal beim Umsatz liefern.

[Aurum2010]

News im Streitfall mit Roquette wären mal nach.

[Mistsack]

Antwort auf Beitrag Nr.: 49.902.172 von Aurum2010 am 03.06.15 10:11:14

die News zu Roquette sollten noch im Juli kommen!

[Aurum2010]

Natura and Solazyme Announce Sales Agreement for Microalgae Oil

Solazyme´s AlgaPūrTM Microalgae Oil to be featured in multiple skincare product lines

SÃO PAULO--(BUSINESS WIRE)-- Natura Cosméticos S.A. (BM&FBOVESPA:NATU3) one of Latin America's largest cosmetics and personal care products company, and Solazyme, Inc. (NASDAQ:SZYM), a renewable oils and ingredients company, announced today that after successfully completing testing and product validation phases over the past year using Solazyme's oils, Natura is purchasing Solazyme's high-performance AlgaPūrTM Microalgae Oil, which will be incorporated into Natura's multiple product lines.

Solazyme's microalgae oils are produced in a matter of days using a fermentation process designed to produce oils of the highest purity, performance and sustainability. Some of the benefits of using AlgaPūr oils for skin care are higher hydration levels, a silky but not greasy skin feel, mildness on the skin, neutral color and odor, and improved shelf life.

Walfredo Linhares, General Manager of Solazyme Bunge Renewable Oils in Brazil, said, "We believe high performance and sustainability belong together. Natura is a leader in innovation and globally recognized for their sustainability efforts. We are very happy to work together to deliver better products for consumers and for our planet."

Natura and Solazyme have been working together for two years on several projects on joint efforts to develop new formulations with Solazyme's microalgae oils. "We are always looking for ingredients from renewable sources and technologies inspired in the nature, targeting low environmental impact processes and high performance solutions," says Daniel Gonzaga, Director of Advanced Research of Natura. "Solazyme microalgae oil that will compose some of our products are a sustainable alternative for new formulations development," he concludes.

Solazyme produces sustainable high performance ingredients for multiple markets and its joint venture facility is located in São Paulo State, in partnership with Bunge.

About Solazyme, Inc.

Solazyme, Inc. develops and sells high-performance oils and ingredients that are better for people and better for the planet. Starting with microalgae, the world's original oil producer, Solazyme creates innovative, sustainable, high-performance products. These include renewable oils and ingredients that serve as the foundation for healthier foods; high-performance industrial products; unique home and personal care solutions; and more sustainable fuels. Headquartered in South San Francisco, Solazyme's mission is to solve some of the world's biggest problems with one of the world's smallest and earliest life forms: microalgae.

For additional information, please visit Solazyme's website at www.solazyme.com.

[Aurum2010]

Volkswagen Completes Successful Renewable Fuel Evaluation With Solazyme and Amyris

Two-Year Trial Evaluated the Effects of Renewable Diesel Solutions With Existing and Next-Generation TDI(R) Clean Diesel Applications

Volkswagen of America, Inc. today announced the successful completion of its Renewable Diesel Evaluation Program in collaboration with Solazyme, Inc. (NASDAQ: SZYM) and Amyris, Inc. (NASDAQ: AMRS), two of the world's leaders in renewable fuels and products. Beginning in 2012, Volkswagen measured the environmental impacts from the use of pre-commercial renewable diesel formulas with TDI® Clean Diesel technology found in the 2012 Passat TDI (which uses a NOx storage system) and 2012 Jetta TDI (SCR system). Initial analysis found that advanced renewable fuels in the test offered comparable performance to standard crude-based diesel fuel blends while producing less CO2 emissions on average.

During the two-year evaluation, Solazyme's, now commercial, Soladiesel RD® (100-percent algae-derived renewable diesel fuel) and the Amyris plant-sugar derived renewable diesel formula was used for the program with each company testing a 2012 Passat TDI and Jetta TDI models. Both fuel producers added additives, which are commonly used today, to meet ASTM D 975 specifications. With more than 134,000 miles logged collectively in real-world, on-road and on-highway conditions, Volkswagen engineers found that every vehicle in the evaluation offered similar performance to existing TDI powertrains operating on today's crude-based clean diesel fuels. While powered by the two fuel formulas, results from the evaluation found that driving dynamics were not negatively impacted while fuel economy was similar or improved. In addition to comparable performance, both producers claim that greenhouse gas emissions (GHG) could be reduced by more than 50 percent on a well-to-wheel basis when using renewable fuels as compared to today's commercially available crude-based fuels.

"The successful completion of this collaboration with two leaders in renewable fuels and products highlights how far advanced fuel technology has come in recent years, proving that sustainable fuels are not only produced in more environmentally friendly ways, but can offer similar performance and lower emissions from a well-to-wheel perspective when compared with commercially available crude-based fuels," said Ewald Goessmann, executive director, Volkswagen Group of America, Electronics Research Laboratory. "Evaluations like this are part of Volkswagen's broader holistic environmental strategy which underscores the company's commitment to the environment by deploying a comprehensive approach which addresses carbon reduction and sustainability at each part of the vehicle lifecycle."

These key indicators highlight the tremendous market potential that renewable fuel solutions offer, combining comparable performance and fuel economy, helping reduce emissions, while utilizing more sustainable methods to produce the products.

During the evaluation period, no engine errors were triggered as a result of the fuel and no extreme wear or failures were reported that would prevent any of the vehicles tested from being operated normally while powered with the respective renewable formulas. Additionally, engineers found that during the evaluation period there were no negative effects in the burning of the renewable fuels, while the production of soot was lower than when using conventional diesel.

"We thank Volkswagen for its support in collaborating with Amyris to showcase the benefits of using our No Compromise® renewable diesel," said John Melo, President & CEO of Amyris, Inc. "These results demonstrate the benefits of using Amyris diesel, and contribute to increased consumer awareness and adoption of renewable fuels."

"We commend Volkswagen for their vision in setting up this program and their broad efforts to deliver more sustainable vehicles to consumers," said Graham Ellis, Senior Vice President of Business Development and Fuels for Solazyme. "Volkswagen's demonstration in the real world that Solazyme's 100 percent drop-in renewable diesel is compatible with existing infrastructure and vehicles is an important step, and has been instrumental in the commercial launch of our fuels."

As the evaluation comes to a close, the results and data collected make for a promising case for the use of renewable fuels in the years to come. The positive results highlight the possibility for new sustainable production pathways and open the door to more advanced innovation in the renewable fuel space. Volkswagen engineers will continue to analyze engine components and other data accumulated during the evaluation which could help in the enhancement of future vehicle components and refinement of renewable fuels.

The renewable diesel evaluation program is part of Volkswagen's global strategy to become one of the world's most environmentally friendly automakers by 2018. From a product perspective, the company seeks to reduce passenger fleet CO2 with a goal of cutting emissions by 90 percent by 2050, improving fuel efficiency by 10-15 percent for every new model as compared to its predecessor, and by making other significant environmental improvements for each new model that's introduced. In production, the brand is working to continue current efforts to help reduce GHG emissions at each production facility globally while increasing the use of renewable forms of energy to power production. For more information about Volkswagen Group's global sustainability efforts, please visit http://sustainabilityreport2014.volkswagen.ag.com/

About Amyris, Inc. Amyris is the integrated renewable products company that is enabling the world's leading brands to achieve sustainable growth. Amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules, specialty ingredients and consumer products. The company is delivering its No Compromise® products in focused markets, including specialty and performance chemicals, fragrance ingredients, and cosmetic emollients. More information about the company is available at www.amyris.com.

Amyris and No Compromise are trademarks or registered trademark of Amyris, Inc.

About Solazyme, Inc.Solazyme, Inc. develops and sells high-performance oils and ingredients that are better for people and better for the planet. Starting with microalgae, the world's original oil producer, Solazyme creates innovative, sustainable, high-performance products. These include renewable oils and ingredients that serve as the foundation for healthier foods; high-performance industrial products; unique home and personal care solutions; and more sustainable fuels. Headquartered in South San Francisco, Solazyme's mission is to solve some of the world's biggest problems with one of the world's smallest and earliest life forms: microalgae.

Soladiesel RD is a registered trademark of Solazyme, Inc. For additional information, please visit Solazyme's website at www.solazyme.com.

About Volkswagen of America, Inc.Founded in 1955, Volkswagen of America, Inc., an operating unit of Volkswagen Group of America, Inc. (VWoA), is headquartered in Herndon, Virginia. It is a subsidiary of Volkswagen AG, headquartered in Wolfsburg, Germany. VWoA's operations in the United States include research and development, parts and vehicle processing, parts distribution centers, sales, marketing and service offices, financial service centers, and its state-of-the-art manufacturing facility in Chattanooga, Tennessee. The Volkswagen Group is one of the world's largest producers of passenger cars and Europe's largest automaker. VWoA sells the Beetle, Beetle Convertible, CC, Eos, e-Golf, Golf, Golf GTI, Golf R, Golf SportWagen, Jetta, Passat, Tiguan and Touareg vehicles through approximately 652 independent U.S. dealers.

Notes: This press release and images are available at media.vw.com. Follow us @VWNews: #VWTDI, #VWThinkBlue.

"TDI", "Volkswagen", all model names and the Volkswagen logo are registered trademarks of Volkswagen AG.

[Aurum2010]

Solazyme Bunge Renewable Oils Completes Key Redundant Power and Steam Supplies

SAO PAULO--(BUSINESS WIRE)-- Solazyme Bunge Renewable Oils, a joint venture between Solazyme, Inc. (NASDAQ:SZYM) and Bunge Global Innovation LLC, a division of Bunge Limited (NYSE:BG), provided an update on engineering activities at the production facility in Orindiuva, Brazil.

Bunge and Solazyme Bunge Renewable Oils have successfully completed two key power and steam redundancy improvement projects including the construction and activation of an electrical grid tie-in, and the tie-in and activation of a second steam boiler. These projects were completed within the previously provided timeline and are now operational. Solazyme Bunge Renewable Oils will continue to evaluate the performance of these projects and may take additional actions in the future to further improve power and steam reliability if necessary.

"We are pleased with the significant work Bunge and the partners have undertaken to improve power and steam reliability," said Walfredo Linhares, General Manager of Solazyme Bunge Renewable Oils. "We continue to make progress as we optimize manufacturing operations with modest production volumes in the near term, and will then move toward ramping production as overall capability allows."

[Aurum2010]

Antwort auf Beitrag Nr.: 50.081.889 von Aurum2010 am 30.06.15 15:08:22

BASF and Solazyme Launch the First Commercial Microalgae-Derived Betaine Surfactant

World's first commercially available high-performance microalgae betaine for use in home and personal care applications

SAN FRANCISCO & FLORHAM PARK, N.J.--(BUSINESS WIRE)-- BASF and Solazyme, Inc., a renewable microalgae oil and ingredients company, announce the launch of the first commercial surfactant derived from microalgae oil, a high performance algal betaine for use in home and personal care applications.

Commercialized by BASF under the trade name Dehyton® AO 45, algal betaine is a betaine surfactant made from renewable microalgae oil. The new algal betaine is a high- performance alternative to amidopropyl betaine in products that require rich and gentle foam such as shampoos, liquid soaps, hand dishwashing liquids, and other applications. Amidopropyl betaines are amphoteric surfactants increasingly used in cosmetic, toiletry and home care applications due to their vast benefits and are known to have: good detergency, good foam properties and foam stabilization, hard water compatibility, mildness to skin and hair, ability to reduce irritation of anionic systems, viscosity building, conditioning effect, stability at a broad range of pH, and excellent biodegradability.

Dehyton® AO 45 is produced with Solazyme AlgaPūr™ Microalgae Oils. AlgaPūr™ Oils are produced with Solazyme's state-of-the-art technology in a matter of days, using a highly controlled fermentation process to convert sugarcane into oils of the highest purity and performance. AlgaPūr™ Microalgae Oils are produced with low carbon, water and land use impact1.

"Consumer demand for sustainable and innovative surfactants has increased significantly, particularly in the home and personal care markets," said Josef Koester, Director Marketing Home and Personal Care, Sustainability Care Chemicals, BASF North America. "Combining BASF's chemistry expertise with Solazyme's unique range of renewable microalgae oils allows us to deliver products that meet this demand."

"We are excited to partner with BASF to launch the world's first commercial microalgae-derived betaine surfactant." said Robert Webber, Chief Commercialization Officer, Solazyme. "BASF's broad capabilities in chemical conversion of triglyceride oils and deep expertise in surfactants enable significant growth opportunities in the future."

[Aurum2010]

UPS Makes Substantial Move to Renewable Fuels

Announces Three New Renewable Fuels Agreements

ATLANTA, July 29, 2015 - UPS® (NYSE:UPS) today announced agreements for up to 46 million gallons of renewable fuels over the next three years, constituting a 15-fold increase over prior contracts and making UPS one of the largest users of renewable diesel in the world.

The agreements with three leading suppliers of renewable fuels, secure access to an advanced renewable diesel fuel in order to meet the company's objectives for alternative fuel utilization. Neste, Renewable Energy Group (REG) and Solazyme will supply renewable diesel to UPS to help facilitate the company's shift to move more than 12% of its purchased ground fuel from conventional diesel and gasoline fuel to alternative fuels by the end of 2017. UPS has previously announced a goal of driving one billion miles with our alternative fuel and advanced technology vehicles by the end of 2017.

"Advanced alternative fuels like renewable diesel are an important part of our strategy to reduce the carbon emissions impact of our fleet," said Mark Wallace, UPS senior vice president, global engineering and sustainability. "We have used more than three million gallons of renewable diesel to date with positive results. Renewable diesel has a huge impact significantly reducing lifecycle greenhouse gas emissions by up to 90 percent less versus conventional petroleum diesel. Renewable diesel also performs well in cold weather, does not have any blending limitations and can be easily 'dropped in' to our fuel supply chain without modifications to our existing diesel trucks and equipment."

Renewable diesel is an advanced hydrocarbon-based fuel that is fully interchangeable with petroleum diesel and offers superior performance and benefits, much like how synthetic lubricants are used in cars instead of petroleum-based lubricants. Bio-based feedstocks from fats, plant oils and waste residues are converted to renewable diesel using advanced refining technologies. These new bio-refineries also have the capability to produce other renewable fuels such as renewable jet fuel, renewable gasoline and renewable propane.

"UPS believes these agreements are especially important because they will help stimulate demand for investment in refinery technologies and sustainable feedstocks needed to produce renewable fuels at a total cost that is comparable to more carbon-intensive petroleum fuels," said Wallace.

UPS has been using renewable fuels for more than a year in trucks operating in Texas and Louisiana. The new agreements pave the way for expanded use across the U.S. and potentially in parts of Europe.

Neste, headquartered in Espoo, Finland, is the world's largest producer of renewable diesel. Neste produces NEXBTL renewable diesel from a variety of feedstocks including more than half from waste and residues.

REG, headquartered in Ames, Iowa, produces renewable hydrocarbon diesel fuel from waste vegetable oils and animal fats at its Geismar, Louisiana, bio-refinery as well as biodiesel at nine bio refining locations in the U.S.

Solazyme, headquartered in San Francisco, produces a blended fuel made from microalgae and other renewable feedstocks.

"Developing alternative, economically viable energy sources is critical to UPS's commitment to reduce our environmental impact, improve communities and foster economic development opportunities around the world," Wallace said.

Additionally, earlier today, UPS released its 13th annual 2014 Corporate Sustainability Report, highlighting its growing investment in alternative fuel and advanced technology vehicles. For more information on UPS's sustainability initiatives, please visit www.ups.com/sustainability.

[R-BgO]

diese Woche kam der 10k,

in der begleitenden Präsentation findet sich kein Wort mehr über Biofuels;

stattdessen soll es jetzt ein TerraVia genanntes Algenfutterpulver richten...


Zahlen gewohnt blutig: Umsatz ein Drittel auf rund 40 MUSD runter, 140 MUSD Miese und EK hat jetzt das falsche Vorzeichen.

[R-BgO]

http://seekingalpha.com/article/3957942-solazyme-evolves-ter…

[R-BgO]

Umbenennung ist durch,

hier geht's weiter

Thread: Terravia